Palvella Therapeutics Stock Forecast

Stock Price Forecast

The 16 analysts that cover Palvella Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $161.13, which forecasts a 41.45% increase in the stock price over the next year. The lowest target is $38 and the highest is $255.

Price Target: $161.13 (+41.45%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$38	$161.13	$190	$255
Change	-66.64%	+41.45%	+66.80%	+123.86%

Analyst Ratings

The average analyst rating for Palvella Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	8	9	12	12	12	12
Buy	4	4	4	5	5	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	13	16	17	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $210	Strong Buy	Maintains	$210	+84.36%	Mar 16, 2026
Graig Suvannavejh Mizuho	Mizuho	Buy Maintains $205 → $250	Buy	Maintains	$205 → $250	+119.47%	Feb 25, 2026
Jeet Mukherjee BTIG	BTIG	Strong Buy Maintains $192 → $215	Strong Buy	Maintains	$192 → $215	+88.75%	Feb 25, 2026
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $174 → $210	Strong Buy	Maintains	$174 → $210	+84.36%	Feb 24, 2026
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $200 → $255	Strong Buy	Maintains	$200 → $255	+123.86%	Feb 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

27.20K

EPS This Year

-3.59

from -7.83

EPS Next Year

-3.95

from -3.59

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	27.20K	24.84M	88.59M
Revenue Growth	-	-	-	-	-	91,201.09%	256.70%
EPS	-4.82	2.17	-7.83	-3.59	-3.95	-5.11	-3.16
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	18	18	15	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	420,000
Avg	n/a	27,203
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-3.00	-3.03
Avg	-3.59	-3.95
Low	-3.61	-4.95

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.